Jan. 26, 2006 -- The US Food and Drug Administration (FDA) and Bristol-Myers Squibb have notified healthcare professionals via letter regarding revisions to the safety labeling for hydroxyurea ...

Hydroxyurea is an oral chemotherapy drug that doctors may prescribe to people with sickle cell disease. It may help prevent complications due to sickle-shaped blood cells clumping together in small ...

Please provide your email address to receive an email when new articles are posted on . Three-quarters of women who became pregnant during hydroxyurea therapy had live births. Researchers observed no ...

Please provide your email address to receive an email when new articles are posted on . Adolescents with sickle cell disease who received visits and text messages from community health workers ...